Table 1.
Inclusion criteria: | Exclusion criteria: | |
---|---|---|
Population |
Adults aged 18 and over People with diabetes mellitus and end stage kidney disease on long term dialysis (peritoneal or haemodialysis) Receiving glucose lowering medication |
Chronic kidney disease not receiving dialysis Acute Kidney injury |
Study design |
Randomised clinical trials, clinical trials and observational studies. Minimum follow up duration of 6 weeks Minimum sample size 10 participants |
Other study designs: case study, case series and review articles |
Intervention | Continuous Glucose Monitoring (isCGM and rtCGM) | |
Outcomes |
Primary outcomes: overall glycaemic control determined by Time in Range (TIR), Time Above Range (TAR) and Time Below Range (TBR) Secondary outcomes: estimated HbA1c, episodes of severe hypoglycemia, number of hospitalisations, patient compliance with glucose scanning, quality of life |
Other outcome measures |
Others |
Published in English language Papers published in peer-reviewed-journals |
Articles published before year 1999 |